Affix Labs Oy

Based in Finland, Affix Labs Oy is a company focused on developing innovative, eco-friendly chemical solutions, notably insect repellents, designed to provide effective protection while minimizing environmental impact. Affix Labs Oy specializes in creating advanced insect repellent products. Founded in 2019 and headquartered in Helsinki, Finland, the company emerged from a focus on sustainable pest control solutions. The firm's only funding round occurred in April 2026 when it raised EUR 1 million from investors VP Capital and Oost NL.

The founder's previous entrepreneurial background is not detailed publicly. Affix Labs specializes in innovative insect repellent solutions, primarily through its flagship product, Repeltec. This product is a long-lasting, water-based insect repellent designed to replace traditional insecticides that rely on toxic killing agents. Repeltec offers up to 12 weeks of protection and is biodegradable, positioning it as a safe alternative for families, pets, and individuals with health sensitivities.

The company targets a diverse customer base, including home users, businesses, and public spaces worldwide, signaling a strong presence in markets that demand safer pest control solutions. Repeltec is particularly suitable for sensitive indoor environments like kitchens and play areas, where conventional pesticides are often unsuitable. The company’s products are marketed in various regions, including North America, Europe, and parts of Asia, catering to an increasing demand for eco-friendly and non-toxic pest control options. Affix Labs generates revenue through a combination of direct consumer sales and partnerships with distributors and retailers.

Transactions typically involve the sale of Repeltec and other related products, which are marketed as non-toxic and environmentally friendly alternatives to conventional insecticides. The company employs a business-to-business (B2B) model, allowing retailers to stock and sell their products under white-label agreements, enhancing brand visibility while maintaining the integrity of Affix Labs' formulations. Pricing structures for their products reflect the emphasis on quality and safety, aligning with the premium positioning of Repeltec in the market. The firm’s strategic partnerships not only facilitate market penetration but also support their commitment to sustainable practices, further solidifying their revenue streams in a competitive landscape.

In April 2026, Affix Labs Oy raised EUR 1 million in venture funding co-led by new investors VP Capital and Oost NL. The company will use the funding to support the rollout of Repeltec across multiple European markets and advance its patented water-based solubility and controlled-release technology. Affix Labs aims to design and launch additional related products in the coming years, broadening its range within the eco-friendly pest control sector.